Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib

Letter/Communication

HAF Stessman, A Mansoor, F Zhan, S Janz, M A Linden, L B Baughn and B Van Ness

Leukemia, Vol.27(10), pp.2075-2077

10/2013

DOI: 10.1038/leu.2013.148

PMCID: PMC4053943

PMID: 23728080

View Online

Title: Subtitle: Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib
Creators: HAF Stessman - Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA
A Mansoor - Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA
F Zhan - Department of Masonic Cancer Center Bioinformatics Support and Services, University of Minnesota, Minneapolis, MN, USA
S Janz - Department of Pathology, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA, USA
M A Linden - Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA
L B Baughn - Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA
B Van Ness - Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA
Resource Type: Letter/Communication
Publication Details: Leukemia, Vol.27(10), pp.2075-2077
DOI: 10.1038/leu.2013.148
PMID: 23728080
PMCID: PMC4053943
ISSN: 0887-6924
eISSN: 1476-5551
Language: English
Date published: 10/2013
Academic Unit: Pathology; Internal Medicine
Record Identifier: 9984083875702771

20 Record Views